We love showcasing the person-centred work you do!

Four standout oral abstracts were chosen for plenary. Thanks to Emma Davey, Dr. Jeff Hanna, Rachel O’Malley and Mary Albiona, for demonstrating nurses’ vital role in reducing disparities & changing practice.

#UKONS2025
#20YearsUKONS

Apixaban is often the DOAC of choice for cancer-related VTE because its safer than rivaroxaban (quoted thread)
Its also cheaper in UK.
Further, this systematic review found reducing apixaban to 2.5mg BD after 6 months reduced bleeding risk without increasing VTE recurrence
doi.org/10.1016/j.th...

We’re back for day two of the UKASCC Supportive Oncology Conference 2025!

We have more great sessions, inspiring discussions, and shared expertise ahead - stay tuned for highlights throughout the day 💫

#UKASCC25

Anyone been skiing in Trysil, Norway before? What’s the food situation- are there restaurants/shops to enable self catering or is it a full-board or starve kinda operation?

New open access article in Supportive Care in Cancer: Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol

link.springer.com/article/10.1...

#SuppOnc #PallOnc

#PalliativeCare is a powerful layer of support that honors the whole person — not just the illness.
Let’s reframe the conversation and ensure more people benefit from this essential component of care 💜🧡!
@pallonccop.bsky.social

In people with cancer-related VTE (NEJM, RCT, n=1766), dropping their apixaban to 2.5mg BD after 6 months was non-inferior for VTE recurrence and led to fewer clinically relevant bleeding complications
www.nejm.org/doi/abs/10.1...

Letter in today’s @theguardian.com from me and 34 other health and care professionals on the assisted dying panels.

Unfortunately they have cut 33 signatories - including social workers, psychiatrists, geriatricians.

This must be corrected.

www.theguardian.com/theobserver/...

Dear @theguardian.com Why have you culled 33 signatories from our letter in today's Observer? Mainly medics, responding to last week's full signatory letter on #AssistedDying? www.theguardian.com/theobserver/...

If you provide care to people with cancer in any capacity, we want to understand your experience with MASCC Guidelines. 
 
Please complete this short survey by March 14: www.surveymonkey.com/r/QL2HWGY

#OncSky @oncoalert.bsky.social @maryamlustberg.bsky.social @europeancancer.bsky.social

I've just joined Blue Sky - please say hello 👋so I can find like-minded people! Interests in palliative care and bereavement, improving quality and addressing inequities. bsky.app/profile/catr...

Podcasts can kill
Thanks to @jacquiwak.bsky.social @bbcworldservice.bsky.social for giving @parthaskar.bsky.social and myself a platform to air our concerns

www.bbc.co.uk/news/article...

💥💊Psychostimulants💊💥

1/4 Psychostimulants for the management of depression in palliative care. A 🧵

#palliative #pharmacology #depression